India Steroid Hormone Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Steroid Hormone Market was valued at USD 661.0 million in 2025 and is projected to reach USD 1,068.38 million by 2032, growing at a CAGR of approximately 7.1% during 2026–2032.
India Steroid Hormone Market Highlights
| Report Metric | Details |
| Report Name | India Steroid Hormone Market |
| Market Size 2025 | USD 661.0 million |
| Market Size 2032 | USD 1,068.38 million |
| Absolute Growth 2025–2032 | USD 407.38 million |
| CAGR 2026–2032 | 7.1% |
| Peak Annual Growth | 9.3% in 2027 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Hormone Type, 2025 | Corticosteroids (38% share) |
| Leading Source, 2025 | Synthetic (48% share) |
| Leading Application Area, 2025 | Anti-inflammatory Drugs (40% share) |
| Leading End User, 2025 | Pharmaceutical Companies (40% share) |
| Fastest-Growing Hormone Type | Anabolic Steroids (9.2% CAGR) |
| Fastest-Growing Source | Biosynthetic (8.2% CAGR) |
| Fastest-Growing Application Area | Hormonal Treatments (8.5% CAGR) |
| Fastest-Growing End User | Drug Developers (9.0% CAGR) |
| Growing Sector | Pharmaceuticals |
| Key End Users | Pharmaceutical Companies, Healthcare Manufacturers, Drug Developers |
India Steroid Hormone Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Year by year, the estimates below pair each growth rate with the development that shaped it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.7 | The market experienced steady growth due to rising demand from pharmaceutical companies for corticosteroids. |
| 2023 | 6.4 | Growth accelerated as corticosteroids gained prominence in treating asthma and arthritis, increasing prescriptions. |
| 2024 | 5.7 | A slowdown occurred as the market adjusted to the regulatory changes from the Drug and Cosmetics Act amendments. |
| 2025 | 4.6 | Continued regulatory adjustments contributed to a further slowdown in growth rates, affecting new product launches. |
| 2026 | 5.3 | Growth is expected to pick up as the 'Pharma Vision 2025' initiative boosts domestic production capabilities. |
| 2027 | 9.3 | A peak in growth is projected as anabolic steroids gain traction in muscle-wasting treatments, driving demand. |
| 2028 | 5.4 | Growth will slow again as the market stabilises after rapid expansion in previous years, adjusting to new norms. |
| 2029 | 5.0 | A further slowdown is anticipated as market conditions normalise post-peak growth, with fewer new entries. |
| 2030 | 8.6 | Growth is expected to rebound as demand for hormonal contraceptives surges ahead of projected targets, increasing production. |
| 2031 | 9.0 | An increase in growth will be driven by advancements in steroid hormone therapies and new formulations entering the market. |
| 2032 | 7.2 | The market growth rate is projected to slow as it approaches maturity, stabilising at a high level with established products. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Steroid Hormone Market Synopsis
The Steroid Hormone Market in India encompasses various steroid hormones produced naturally or synthetically, primarily for therapeutic uses. These hormones are essential in treating conditions such as inflammation and hormonal imbalances. The market is growing due to rising demand from pharmaceutical companies and healthcare sectors, with an estimated 1.5 million patients receiving corticosteroid treatments annually. The 'Pharma Vision 2025' initiative aims to improve pharmaceutical manufacturing, further boosting market potential.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing prevalence of asthma and arthritis drives demand for corticosteroids. | Driver | High | Corticosteroids |
| Rising incidence of muscle-wasting diseases boosts the need for anabolic steroids. | Driver | High | Anabolic Steroids |
| Emerging biosynthetic steroid hormone production presents new investment opportunities. | Opportunity | High | Biosynthetic |
| The growing market for hormonal contraceptives opens avenues for suppliers. | Opportunity | High | Hormonal Treatments |
| Regulatory changes can delay drug approvals, impacting market entry. | Restraint | High | Synthetic |
| Price regulations by the National Pharmaceutical Pricing Authority can limit profit margins. | Restraint | Medium | Corticosteroids |
| Challenges in sourcing high-quality raw materials affect production timelines. | Challenge | High | Anabolic Steroids |
| Competition from alternative therapies can reduce market share for steroid hormones. | Challenge | Medium | Hormonal Treatments |
Evaluation of Drivers in India Steroid Hormone Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Rising prevalence of asthma and arthritis. | Corticosteroids | An estimated 1.5 million patients receive corticosteroid treatments annually, increasing demand from healthcare providers. |
| Growing incidence of muscle-wasting diseases. | Anabolic Steroids | Hospitals frequently prescribe anabolic steroids, driving demand for muscle growth therapies in clinical settings. |
| Increased investment in biosynthetic hormone research. | Biosynthetic | The Ministry of Health and Family Welfare initiated a program to promote research on biosynthetic steroid hormones, enhancing innovation. |
| Expansion of hormonal contraceptive market. | Hormonal Treatments | The market for hormonal contraceptives is projected to reach 1 billion units by 2025, spurring demand from manufacturers. |
| ISO 9001:2015 certification among manufacturers. | Synthetic | Certification ensures quality standards, attracting pharmaceutical companies to source from compliant producers. |
Growth in the Steroid Hormone market in India comes from rising prevalence of asthma and arthritis, which increases demand for corticosteroids. An estimated 1.5 million patients receive corticosteroid treatments annually, prompting healthcare providers to source more products. The growing incidence of muscle-wasting diseases drives hospitals to frequently prescribe anabolic steroids, increasing market demand. The expansion of the hormonal contraceptive market, projected to reach 1 billion units by 2025, drives demand from pharmaceutical companies seeking new formulations.
Evaluation of Restraints in India Steroid Hormone Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Regulatory changes affecting drug approvals can delay market entry. | Synthetic | The Drug and Cosmetics Act amendments in 2021 streamlined approvals but still pose challenges for new products. |
| Price regulations by the National Pharmaceutical Pricing Authority limit profit margins. | Corticosteroids | These regulations restrict pricing flexibility for manufacturers, impacting profitability and investment. |
| Challenges in sourcing high-quality raw materials can disrupt production. | Anabolic Steroids | Quality issues can delay manufacturing timelines, affecting supply to healthcare providers and patient access. |
| Competition from alternative therapies can impact market share. | Hormonal Treatments | As new therapies emerge, they may divert attention and resources away from steroid hormones, affecting sales. |
| Limited awareness of biosynthetic options among healthcare providers slows adoption. | Biosynthetic | Despite potential benefits, healthcare professionals may hesitate to prescribe these newer options, limiting market growth. |
India Steroid Hormone Market Challenges
The India Steroid Hormone Market faces supply chain disruptions due to regulatory hurdles that delay drug approvals, costing suppliers valuable time and resources. Patients relying on corticosteroids, estimated at 1.5 million annually, may experience inconsistent availability, leading to potential delays in care. Increased competition among local manufacturers has sparked price wars that can compromise product quality and force suppliers to lower standards, jeopardising patient safety. Rising production costs associated with strict ISO 9001:2015 compliance requirements have driven prices higher for buyers, affecting their purchasing decisions.
Trends in the India Steroid Hormone Market
Four trends stand out in the India Steroid Hormone Market.
- Pharmaceuticals Mission Initiatives: The Pharmaceuticals Mission, launched in 2020, aims to boost domestic production of steroid hormones. This initiative has an estimated funding of USD 1 billion allocated for development projects.
- Shift Towards Biosynthetic Hormones: Since 2022, there has been a notable shift towards biosynthetic steroid hormones in India. The Ministry of Health and Family Welfare's program promotes research in this area, with over 200 studies published in 2023.
- Increased Focus on Hormonal Treatments: As of 2025, hormonal treatments have gained traction in the Indian market. The projected growth of hormonal contraceptives to 1 billion units highlights the rising interest in these therapies.
- Regulatory Updates for Anabolic Steroids: In 2023, the Central Drugs Standard Control Organization updated guidelines for anabolic steroids. This change is expected to streamline regulation, encouraging more manufacturers to enter the market.
Investment Opportunities in the India Steroid Hormone Market
The following opportunities in the India Steroid Hormone Market pair current demand with a clear way in.
- Maharashtra as a Manufacturing Hub: Maharashtra is currently a key region for steroid hormone production, offering significant investment opportunities. The state's pharmaceutical companies are expanding, driven by the 'Pharma Vision 2025' initiative, which aims to enhance local production capabilities.
- Investment in Biosynthetic Hormones: Now is an ideal time to invest in biosynthetic steroid hormones, as research is gaining momentum. The Indian Council of Medical Research supports these initiatives, providing funding for innovative projects.
- Growing Demand from Drug Developers: Drug developers are increasingly seeking steroid hormones for new therapies. With a projected growth rate of 9.0% for this segment, partnerships with local firms can facilitate market entry.
- Expansion in Hormonal Treatments: The rising demand for hormonal contraceptives presents an opportunity. Suppliers can enter this market by collaborating with healthcare manufacturers to develop new formulations.
Government Initiatives in the India Steroid Hormone Market
The National Health Policy 2021 aims to improve access to essential medicines, including steroid hormones, through better supply chain management. This policy encourages manufacturers to streamline operations and ensure timely availability of products. Additionally, the Department of Pharmaceuticals launched the 'Pharmaceuticals Mission' in 2020, which focuses on boosting domestic production of steroid hormones. This initiative is projected to increase local manufacturing capabilities and reduce reliance on imports, benefiting both producers and buyers.
The Central Drugs Standard Control Organization oversees the approval of steroid-based drugs, ensuring compliance with safety standards. This agency's recent updates to guidelines for anabolic steroids aim to simplify the approval process, facilitating quicker market entry for new products. Furthermore, the Drug Controller General of India plays a key role in regulating the market, approving new steroid formulations and monitoring their safety. These measures improve the regulatory environment for steroid hormones, benefiting manufacturers and consumers alike.
Future Insight of the India Steroid Hormone Market
The India Steroid Hormone Market will undergo considerable transformation by 2032, primarily driven by the 'Pharma Vision 2025' initiative focused on improving local manufacturing capabilities. Buyers will benefit from enhanced access to a wider range of steroid therapies as research institutions contribute valuable studies, with over 200 published in 2023. Streamlined regulatory frameworks will enable quicker drug approvals, allowing suppliers to introduce products to market more efficiently. The projected increase in hormonal contraceptive production to 1 billion units by 2025 will create new opportunities for both suppliers and buyers.
Market Segmentation Analysis
The report offers a comprehensive study of the following market segments and their leading categories in the market.
By Hormone Type – Corticosteroids Dominated, Anabolic Steroids Expected to Grow Fastest
According to Summon Dutta, Assistant Manager at 6Wresearch, in 2025, Corticosteroids led the hormone type split with a 38% share. Corticosteroids dominate the market due to their extensive use in treating conditions like asthma and arthritis. With approximately 1.5 million patients receiving corticosteroid treatments annually, their widespread application reinforces their leading market share in India. Anabolic Steroids are projected to grow fastest, at a CAGR of 9.2% during 2026–2032. Anabolic steroids are experiencing rapid growth as they are increasingly prescribed for muscle-wasting diseases in hospitals. This rising demand for anabolic therapies in clinical settings is expected to drive their swift expansion in the market. Suppliers should focus on increasing the availability of anabolic steroids to meet the growing therapeutic demand.
By Source – Synthetic Dominated, Biosynthetic Expected to Grow Fastest
With a 48% revenue share in 2025, Synthetic was the largest source category. Synthetic steroid hormones hold the largest market share as they are the primary source for pharmaceutical applications. Their established manufacturing processes and reliability make them the preferred choice among producers in India. The quickest growth will come from Biosynthetic, forecast to expand at a CAGR of 8.2% between 2026 and 2032. Biosynthetic sources are emerging quickly, particularly due to their potential in developing targeted therapies. This trend indicates a growing interest in sustainable and precise hormone production methods, reflecting a shift in market preferences. Buyers may benefit from exploring biosynthetic options as they become more prevalent, potentially enhancing treatment efficacy.
By Application Area – Anti-inflammatory Drugs Dominated, Hormonal Treatments Expected to Grow Fastest
Anti-inflammatory Drugs held a 40% share of the India Steroid Hormone Market by application area in 2025. Anti-inflammatory drugs represent the largest application area, primarily due to the extensive use of corticosteroids in treating inflammation and autoimmune conditions. This focus on anti-inflammatory treatments ensures a steady demand for these therapeutic products. Over 2026–2032, Hormonal Treatments are expected to post the fastest growth, at a CAGR of 8.5%. Hormonal treatments are the fastest-growing segment, driven by the increasing need for hormone replacement therapies across various medical situations. The expanding patient base seeking these treatments significantly fuels this growth trajectory. Suppliers should prioritise the development of hormonal treatments to capitalise on this rapidly growing market segment.
By End User – Pharmaceutical Companies Dominated, Drug Developers Expected to Grow Fastest
The largest end user category in 2025 was Pharmaceutical Companies, with a 40% share of total revenue. Pharmaceutical companies are the leading end users of steroid hormones, requiring substantial quantities for drug formulation and production. Their significant market share highlights their central role within the steroid hormone supply chain in India. Drug Developers are set to record the highest CAGR in this split, 9.0% over 2026–2032. Drug developers represent the fastest-growing end user group, propelled by their focus on creating new steroid-based therapies. This trend signals a shift towards innovation and advancement in the steroid hormone sector. Suppliers should engage with drug developers to align their offerings with the latest therapeutic innovations.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Steroid Hormone Market Outlook
- Market Size of India Steroid Hormone Market, 2025
- Forecast of India Steroid Hormone Market, 2032
- Historical Data and Forecast of India Steroid Hormone Revenues & Volume for the Period 2022 - 2032F
- India Steroid Hormone Market Trend Evolution
- India Steroid Hormone Market Drivers and Challenges
- India Steroid Hormone Price Trends
- India Steroid Hormone Porter's Five Forces
- India Steroid Hormone Industry Life Cycle
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Hormone Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Corticosteroids for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Anabolic Steroids for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Estrogens & Androgens for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Progestogens for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Source for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Synthetic for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Plant-Based for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Animal-Based for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Biosynthetic for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Application Area for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Anti-inflammatory Drugs for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Muscle Growth Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Hormonal Treatments for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Birth Control for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Pharmaceutical Companies for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Research Institutions for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Healthcare Manufacturers for the Period 2022 - 2032F
- Historical Data and Forecast of India Steroid Hormone Market Revenues & Volume By Drug Developers for the Period 2022 - 2032F
- India Steroid Hormone Import Export Trade Statistics
- Market Opportunity Assessment By Hormone Type
- Market Opportunity Assessment By Source
- Market Opportunity Assessment By Application Area
- Market Opportunity Assessment By End User
- India Steroid Hormone Top Companies Market Share
- India Steroid Hormone Competitive Benchmarking By Technical and Operational Parameters
- India Steroid Hormone Company Profiles
- India Steroid Hormone Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Hormone Type
- Corticosteroids
- Anabolic Steroids
- Estrogens & Androgens
- Progestogens
By Source
- Synthetic
- Plant-Based
- Animal-Based
- Biosynthetic
By Application Area
- Anti-inflammatory Drugs
- Muscle Growth Therapy
- Hormonal Treatments
- Birth Control
By End User
- Pharmaceutical Companies
- Research Institutions
- Healthcare Manufacturers
- Drug Developers







